APA

Steigbigel R. T., Cooper D. A., Teppler H., Eron J. J., Gatell J. M., Kumar P. N., Rockstroh J. K., Schechter M., Katlama C., Markowitz M., Yeni P., Loutfy M. R., Lazzarin A., Lennox J. L., Clotet B., Zhao J., Wan H., Rhodes R. R., Strohmaier K. M., Barnard R. J., Isaacs R. D. & Nguyen B. T. (20100421). Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials. : Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chicago

Steigbigel Roy T, Cooper David A, Teppler Hedy, Eron Joseph J, Gatell Jose M, Kumar Princy N, Rockstroh Jurgen K, Schechter Mauro, Katlama Christine, Markowitz Martin, Yeni Patrick, Loutfy Mona R, Lazzarin Adriano, Lennox Jeffrey L, Clotet Bonaventura, Zhao Jing, Wan Hong, Rhodes Rand R, Strohmaier Kim M, Barnard Richard J, Isaacs Robin D and Nguyen Bach-Yen T. 20100421. Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials. : Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Harvard

Steigbigel R. T., Cooper D. A., Teppler H., Eron J. J., Gatell J. M., Kumar P. N., Rockstroh J. K., Schechter M., Katlama C., Markowitz M., Yeni P., Loutfy M. R., Lazzarin A., Lennox J. L., Clotet B., Zhao J., Wan H., Rhodes R. R., Strohmaier K. M., Barnard R. J., Isaacs R. D. and Nguyen B. T. (20100421). Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials. : Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

MLA

Steigbigel Roy T, Cooper David A, Teppler Hedy, Eron Joseph J, Gatell Jose M, Kumar Princy N, Rockstroh Jurgen K, Schechter Mauro, Katlama Christine, Markowitz Martin, Yeni Patrick, Loutfy Mona R, Lazzarin Adriano, Lennox Jeffrey L, Clotet Bonaventura, Zhao Jing, Wan Hong, Rhodes Rand R, Strohmaier Kim M, Barnard Richard J, Isaacs Robin D and Nguyen Bach-Yen T. Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials. : Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 20100421.